Browse by Title

Type here to filter the list

I
Identification of patient groups at high risk of fluoroquinolone-associated potentially life-threatening adverse events in German routine care: a population-based cohort study

Julia Wicherski, MSc (she/her/hers) – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology ### 2325588###Presenting Author###PhD candidate###Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology###
Presenting Author: Julia Wicherski, MSc (she/her/hers) – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology
### she/her/hers @@@ Jonas Peltner – German Center for Neurodegenerative Diseases (DZNE), Pharmacoepidemiology in Neurodegenerative Disorders ### 2325177###Co-Author###Research associate###German Center for Neurodegenerative Diseases (DZNE), Pharmacoepidemiology in Neurodegenerative Disorders###
Co-Author: Jonas Peltner – German Center for Neurodegenerative Diseases (DZNE), Pharmacoepidemiology in Neurodegenerative Disorders
### @@@ Cornelia Becker – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology ### 2325589###Co-Author######Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology###
Co-Author: Cornelia Becker – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology
### @@@ Katrin Schüssel – Scientific Institute of the AOK (WIdO) ### 2325590###Co-Author######Scientific Institute of the AOK (WIdO)###
Co-Author: Katrin Schüssel – Scientific Institute of the AOK (WIdO)
### @@@ Gabriela Brückner – Scientific Institute of the AOK (WIdO) ### 2325591###Co-Author######Scientific Institute of the AOK (WIdO)###
Co-Author: Gabriela Brückner – Scientific Institute of the AOK (WIdO)
### @@@ Andreas Schlotmann – Scientific Institute of the AOK (WIdO) ### 2325593###Co-Author######Scientific Institute of the AOK (WIdO)###
Co-Author: Andreas Schlotmann – Scientific Institute of the AOK (WIdO)
### @@@ Helmut Schröder – Scientific Institute of the AOK (WIdO) ### 2325594###Co-Author######Scientific Institute of the AOK (WIdO)###
Co-Author: Helmut Schröder – Scientific Institute of the AOK (WIdO)
### @@@ Winfried Kern – Division of Infectious Diseases, Department of Medicine II, Medical Center-University of Freiburg ### 2325595###Co-Author######Division of Infectious Diseases, Department of Medicine II, Medical Center-University of Freiburg###
Co-Author: Winfried Kern – Division of Infectious Diseases, Department of Medicine II, Medical Center-University of Freiburg
### @@@ Birgitta Weltermann – Institute of General Practice and Family Medicine, University of Bonn ### 2325596###Co-Author######Institute of General Practice and Family Medicine, University of Bonn###
Co-Author: Birgitta Weltermann – Institute of General Practice and Family Medicine, University of Bonn
### @@@ Britta Haenisch – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology ### 2325437###Co-Author######Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology###
Co-Author: Britta Haenisch – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology
###
Identifying adverse drug events in clinical notes of Intensive Care patients: the need for a gold standard corpus to enable automation via Natural Language Processing

Rachel M. Murphy, MPharm MSc (she/her/hers) – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325470###Presenting Author###PhD Student###Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Presenting Author: Rachel M. Murphy, MPharm MSc (she/her/hers) – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### she/her/hers @@@ Dave A. Dongelmans – Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325471###Co-Author######Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Dave A. Dongelmans – Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Nicolette F. de Keizer – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325472###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Nicolette F. de Keizer – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Rosa J. Jongeneel – Amsterdam University Medical Centers ### 2325473###Co-Author######Amsterdam University Medical Centers###
Co-Author: Rosa J. Jongeneel – Amsterdam University Medical Centers
### @@@ Christiaan H. Koster – Department of Anesthesiology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands ### 2325474###Co-Author######Department of Anesthesiology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands###
Co-Author: Christiaan H. Koster – Department of Anesthesiology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
### @@@ Kitty J. Jager – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325475###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Kitty J. Jager – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Ameen Abu-Hanna – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325476###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Ameen Abu-Hanna – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Iacer Calixto – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325477###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Iacer Calixto – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Joanna E. Klopotowska, PharmD, PhD (she/her/hers) – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325203###Co-Author###Assistant Professor, Principal Investigator###Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Joanna E. Klopotowska, PharmD, PhD (she/her/hers) – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### she/her/hers
Identifying Novel Endpoints in Rare Disease Studies Using Real-World Evidence: A Regulatory Science Perspective

Julien E. Heidt, MS – IQVIA ### 2325212###Presenting Author###Senior Consultant Epidemiologist, Regulatory Science and Study Innovation###IQVIA###
Presenting Author: Julien E. Heidt, MS – IQVIA
### @@@ Reid D'Amico, PhD – IQVIA ### 2325480###Co-Author###Principal###IQVIA###
Co-Author: Reid D'Amico, PhD – IQVIA
### @@@ Christina D. Mack, PhD, FISPE – IQVIA ### 2326929###Co-Author###Chief Scientific Officer###IQVIA###
Co-Author: Christina D. Mack, PhD, FISPE – IQVIA
###
Identifying Subgroups Associated with Switching Patterns of Asthma Treatment: A Real-World Drug Utilization Study Using the Parametric G-Formula.

Irene Mommers, MSc – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2328415###Presenting Author###PhD student###PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###
Presenting Author: Irene Mommers, MSc – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Job F M van Boven, PharmD, PhD – University Medical Center Groningen ### 2330951###Co-Author###Associate Professor###University Medical Center Groningen###
Co-Author: Job F M van Boven, PharmD, PhD – University Medical Center Groningen
### @@@ Jens H.J. Bos, BSc – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2327265###Co-Author######PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###
Co-Author: Jens H.J. Bos, BSc – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Sumaira Mubarik, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2327269###Co-Author######PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###
Co-Author: Sumaira Mubarik, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Eelko Hak, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2326059###Co-Author######PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###
Co-Author: Eelko Hak, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Maarten J. Bijlsma, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2327295###Co-Author######PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###
Co-Author: Maarten J. Bijlsma, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
###
Immortal bias from different lengths of grace period in a clone-censor-weight design: a simulation study.

Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1994356###Presenting Author###Research Associate###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Presenting Author: Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his @@@ Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University ### 1991536###Co-Author###Research fellow###National Cheng Kung University###
Co-Author: Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
Immune-Related Adverse Events of Anti-PD-(L)1 Immunotherapy With and Without Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Evidence Study

Ping Shao, M.B.B.S, MS – Regeneron ### 1991789###Presenting Author###Associate Director###Regeneron###
Presenting Author: Ping Shao, M.B.B.S, MS – Regeneron
### @@@ Alexi N. Archambault, PhD, MPH – Regeneron ### 1658114###Co-Author###Assoc Dir Pharmacoepidemiology###Regeneron###
Co-Author: Alexi N. Archambault, PhD, MPH – Regeneron
### @@@ Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals ### 1360408###Co-Author###Sr. Director, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Co-Author: Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals
### he/him/his @@@ Rachel E. E. Sobel, DrPH (she/her/hers) – Regeneron ### 1991877###Co-Author###VP, Head of Pharmacoepidemiology###Regeneron###
Co-Author: Rachel E. E. Sobel, DrPH (she/her/hers) – Regeneron
### she/her/hers @@@ Julius Asubonteng, PhD – Regeneron ### 1991791###Co-Author###Director###Regeneron###
Co-Author: Julius Asubonteng, PhD – Regeneron
### @@@ Gregory P. Geba, MD, DrPH – Regeneron Pharmaceuticals, Inc. ### 1360060###Co-Author######Regeneron Pharmaceuticals, Inc.###
Co-Author: Gregory P. Geba, MD, DrPH – Regeneron Pharmaceuticals, Inc.
### @@@ Asha B. Pillai, MD – Regeneron ### 2325210###Co-Author###Chair, Hematology, Hematologic Malignancies, and Transplantation###Regeneron###
Co-Author: Asha B. Pillai, MD – Regeneron
###
Impact of data source diversity on the distribution of key variables in pregnancy cohorts based on the ConcePTION pregnancy algorithm leveraging a random forest imputation model

Anna Girardi, PharmD, PhD – ARS Toscana ### 1659698###Presenting Author###Collaborator###ARS Toscana###
Presenting Author: Anna Girardi, PharmD, PhD – ARS Toscana
### @@@ Giorgio Limoncella – University of Florence, Florence, Italy ### 1359790###Co-Author###PhD Student###University of Florence, Florence, Italy###
Co-Author: Giorgio Limoncella – University of Florence, Florence, Italy
### @@@ Giulia Hyeraci, PharmD – ARS Toscana ### 1359614###Co-Author###Pharmacoepidemiology consultant###ARS Toscana###
Co-Author: Giulia Hyeraci, PharmD – ARS Toscana
### @@@ Giuseppe Roberto, PhD, PharmD – ARS Toscana, Florence ### 1359195###Co-Author###PharmD, PhD###ARS Toscana, Florence###
Co-Author: Giuseppe Roberto, PhD, PharmD – ARS Toscana, Florence
### @@@ Claudia C. Bartolini – ARS Toscana ### 1063227###Co-Author###Researcher###ARS Toscana###
Co-Author: Claudia C. Bartolini – ARS Toscana
### @@@ Olga Paoletti – ARS Toscana ### 1359270###Co-Author###Researcher###ARS Toscana###
Co-Author: Olga Paoletti – ARS Toscana
### @@@ Davide Messina – ARS Toscana, Florence, Italy ### 1359791###Co-Author###Programmer###ARS Toscana, Florence, Italy###
Co-Author: Davide Messina – ARS Toscana, Florence, Italy
### @@@ Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360560###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991144###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Jesse M. van den Berg, MD (he/him/his) – PHARMO Institute for Drug Outcomes Research ### 1991361###Co-Author###PhD student###PHARMO Institute for Drug Outcomes Research###
Co-Author: Jesse M. van den Berg, MD (he/him/his) – PHARMO Institute for Drug Outcomes Research
### he/him/his @@@ Eline Houben, PhD – PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands ### 1658871###Co-Author###Senior Research Manager###PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands###
Co-Author: Eline Houben, PhD – PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands
### @@@ Katia Santacà, PhD – University of Verona ### 2325272###Co-Author###Postdoctoral Fellow###University of Verona###
Co-Author: Katia Santacà, PhD – University of Verona
### @@@ Valentina Ientile – Italian National Institute for Nuclear Physics ### 2325640###Co-Author######Italian National Institute for Nuclear Physics###
Co-Author: Valentina Ientile – Italian National Institute for Nuclear Physics
### @@@ Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona ### 1993969###Co-Author###Assistant Professor###Department of Diagnostics and Public Health, University of Verona, Verona###
Co-Author: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
### @@@ Gianluca Trifirò, MD, FISPE – Università di Verona ### 1302766###Co-Author###Full Professor of Pharmacology###Università di Verona###
Co-Author: Gianluca Trifirò, MD, FISPE – Università di Verona
### @@@ Vjola Hoxhaj, PharmD, MSc (she/her/hers) – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands ### 1991500###Co-Author###Scientific Programmer & PhD Student###Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands###
Co-Author: Vjola Hoxhaj, PharmD, MSc (she/her/hers) – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands
### she/her/hers @@@ Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht ### 1655741###Co-Author###Assistant Professor###Department of Data Science and Biostatistics, University Medical Center Utrecht###
Co-Author: Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht
### @@@ Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands ### 1991418###Co-Author###PhD candidate###Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands###
Co-Author: Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands
### @@@ Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain ### 1655701###Co-Author######Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain###
Co-Author: Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain
### @@@ Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS) ### 1359445###Co-Author###Pharmacoepidemiologist###Spanish Agency of Medicines and Medical Devices (AEMPS)###
Co-Author: Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS)
### @@@ Consuelo Huerta-Alvarez, MD, MPH, PhD – Complutense University of Madrid ### 1655572###Co-Author######Complutense University of Madrid###
Co-Author: Consuelo Huerta-Alvarez, MD, MPH, PhD – Complutense University of Madrid
### @@@ Ana Llorente-Garcia – Spanish Agency of Medicines and Medical Devices(AEMPS) ### 1359446###Co-Author######Spanish Agency of Medicines and Medical Devices(AEMPS)###
Co-Author: Ana Llorente-Garcia – Spanish Agency of Medicines and Medical Devices(AEMPS)
### @@@ Francisco Sánchez-Sáez, PhD – FISABIO ### 2325273###Co-Author###Researcher###FISABIO###
Co-Author: Francisco Sánchez-Sáez, PhD – FISABIO
### @@@ Gabriel Sanfélix-Gimeno, PharmD, PhD – Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region ### 2325274###Co-Author######Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region###
Co-Author: Gabriel Sanfélix-Gimeno, PharmD, PhD – Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region
### @@@ Clara L. Rodríguez-Bernal, DDS, PhD – Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain ### 2325165###Co-Author###Lead of perinatal pharmacoepidemiology research###Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain###
Co-Author: Clara L. Rodríguez-Bernal, DDS, PhD – Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain
### @@@ Régis Lassalle, MSc – Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France ### 1358268###Co-Author###Head of Statistics and Data management###Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France###
Co-Author: Régis Lassalle, MSc – Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France
### @@@ Jérémy Jové – BPE ### 1358369###Co-Author###Statistician###BPE###
Co-Author: Jérémy Jové – BPE
### @@@ Marie-Agnès Bernard – Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France ### 1658844###Co-Author###Statistician###Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France###
Co-Author: Marie-Agnès Bernard – Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France
### @@@ Nicolas H. Thurin, PharmD, PhD – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux ### 1062878###Co-Author###Special consultant###Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux###
Co-Author: Nicolas H. Thurin, PharmD, PhD – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux
### @@@ Sue Jordan, MB.BCh., PhD. PGCE (FE), – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK ### 1359730###Co-Author###professor###Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK###
Co-Author: Sue Jordan, MB.BCh., PhD. PGCE (FE), – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK
### @@@ Daniel Thayer – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK ### 1658933###Co-Author######Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK###
Co-Author: Daniel Thayer – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK
### @@@ Hywel T. Evans, PhD – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK ### 2325276###Co-Author###Research Officer###Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK###
Co-Author: Hywel T. Evans, PhD – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK
### @@@ Alex Coldea – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK ### 2325278###Co-Author######Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK###
Co-Author: Alex Coldea – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK
### @@@ Marco Manfrini – Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University ### 1900338###Co-Author###Specialist in health statistics and biometrics###Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University###
Co-Author: Marco Manfrini – Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University
### @@@ Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway ### 1062980###Co-Author###Assistant Professor in Pharmacoepidemiology###Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway###
Co-Author: Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway
### @@@ Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 2325297###Co-Author######Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062583###Co-Author###Senior scientist###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Co-Author: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Michele Tari – Caserta Local Health Unit, Caserta ### 1302883###Co-Author###Pharmacist###Caserta Local Health Unit, Caserta###
Co-Author: Michele Tari – Caserta Local Health Unit, Caserta
### @@@ Romin Pajouheshnia, PhD – RTI Health Solutions ### 2325267###Co-Author###Research Epidemiologist###RTI Health Solutions###
Co-Author: Romin Pajouheshnia, PhD – RTI Health Solutions
### @@@ Ana Sofia Afonso – Eli Lilly & Company ### 2325183###Co-Author######Eli Lilly & Company###
Co-Author: Ana Sofia Afonso – Eli Lilly & Company
### @@@ Maryline Le Noan-Lainé – Eli Lilly, Global Patient Safety, Cork Ireland ### 2325184###Co-Author######Eli Lilly, Global Patient Safety, Cork Ireland###
Co-Author: Maryline Le Noan-Lainé – Eli Lilly, Global Patient Safety, Cork Ireland
### @@@ Ditte Mølgaard-Nielsen, PhD – Novo Nordisk ### 1992023###Co-Author######Novo Nordisk###
Co-Author: Ditte Mølgaard-Nielsen, PhD – Novo Nordisk
### @@@ Marianne Cunnington, PhD (she/her/hers) – Analysis Group, Inc., London, UK ### 1991261###Co-Author###Vice President###Analysis Group, Inc., London, UK###
Co-Author: Marianne Cunnington, PhD (she/her/hers) – Analysis Group, Inc., London, UK
### she/her/hers @@@ Caitlin N. Dodd, PhD (she/her/hers) – Panalgo ### 1659256###Co-Author###Associate Director, Analytic Services###Panalgo###
Co-Author: Caitlin N. Dodd, PhD (she/her/hers) – Panalgo
### she/her/hers @@@ Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###
Co-Author: Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers
Impact of initial opioid prescription on risk of incident opioid use disorder among patients newly diagnosed with musculoskeletal pain

Allison Perry, PhD – Norstella ### 2325421###Presenting Author###Director, RWD Engagement Management###Norstella###
Presenting Author: Allison Perry, PhD – Norstella
### @@@ Michael J. Munsell, PhD – Panalgo ### 1661018###Co-Author###Director of Research###Panalgo###
Co-Author: Michael J. Munsell, PhD – Panalgo
### @@@ Sydnie Stackland, MS – Panalgo ### 2325422###Co-Author######Panalgo###
Co-Author: Sydnie Stackland, MS – Panalgo
### @@@ Chelsea Dutra, MPH – Panalgo ### 2325423###Co-Author######Panalgo###
Co-Author: Chelsea Dutra, MPH – Panalgo
### @@@ Magdalena Cerdá, DrPH ### 2429545###Co-Author#########
Co-Author: Magdalena Cerdá, DrPH
###
Impact of Kentucky Medicaid Prior Authorization Removal on Dispensing and Continuity of Buprenorphine for the Treatment of Opioid Use Disorder

Dustin K. Miracle, PharmD, MS – University of Kentucky College of Pharmacy ### 1658813###Presenting Author###Graduate Research Assistant###University of Kentucky College of Pharmacy###
Presenting Author: Dustin K. Miracle, PharmD, MS – University of Kentucky College of Pharmacy
### @@@ Lindsey R. Hammerslag, PhD – University of Kentucky ### 1655863###Co-Author###Assistant Research Professor###University of Kentucky###
Co-Author: Lindsey R. Hammerslag, PhD – University of Kentucky
### @@@ Svetla Slavova, PhD – University of Kentucky ### 1359478###Co-Author###Professor###University of Kentucky###
Co-Author: Svetla Slavova, PhD – University of Kentucky
### @@@ Michelle Lofwall, MD, DFAPA, DFASAM – University of Kentucky ### 1360578###Co-Author###Professor###University of Kentucky###
Co-Author: Michelle Lofwall, MD, DFAPA, DFASAM – University of Kentucky
### @@@ Jeffery Talbert, PhD – University of Kentucky College of Medicine ### 1360576###Co-Author###Professor###University of Kentucky College of Medicine###
Co-Author: Jeffery Talbert, PhD – University of Kentucky College of Medicine
### @@@ Sharon L. Walsh, PhD – University of Kentucky ### 1360577###Co-Author###Professor###University of Kentucky###
Co-Author: Sharon L. Walsh, PhD – University of Kentucky
### @@@ Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy ### 1656010###Co-Author###Professor###University of Kentucky College of Pharmacy###
Co-Author: Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy
###
Impact of Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Diseases and Antibiotic Prescribing in the United Kingdom

Lydia E. Gamey – School of Pharmacy, Queen's University Belfast ### 2325418###Presenting Author###Doctoral Student###School of Pharmacy, Queen's University Belfast###
Presenting Author: Lydia E. Gamey – School of Pharmacy, Queen's University Belfast
### @@@ Carmel Hughes – School of Pharmacy, Queen's University Belfast ### 2325419###Co-Author######School of Pharmacy, Queen's University Belfast###
Co-Author: Carmel Hughes – School of Pharmacy, Queen's University Belfast
### @@@ Wallis Lau, PhD – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom. ### 1063024###Co-Author######Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.###
Co-Author: Wallis Lau, PhD – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.
### @@@ Boqing Chen, MSc (he/him/his) – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom. ### 1993239###Co-Author###PhD student###Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.###
Co-Author: Boqing Chen, MSc (he/him/his) – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.
### he/him/his @@@ Konstantinos Karampatsas – Centre for Neonatal and Paediatric Infection, St. George’s University of London ### 2325420###Co-Author######Centre for Neonatal and Paediatric Infection, St. George’s University of London###
Co-Author: Konstantinos Karampatsas – Centre for Neonatal and Paediatric Infection, St. George’s University of London
### @@@ Yingfen Hsia – School of Pharmacy, Queen's University Belfast ### 1655894###Co-Author######School of Pharmacy, Queen's University Belfast###
Co-Author: Yingfen Hsia – School of Pharmacy, Queen's University Belfast
###
Impact of Risk Evaluation and Mitigation Strategies on Teratogenic Medications Among Publicly and Privately Insured Reproductive-Age Women

Yanmin Zhu, MS, PhD – Brigham and Women's Hospital and Harvard Medical School ### 1063282###Presenting Author###Instructor in Medicine###Brigham and Women's Hospital and Harvard Medical School###
Presenting Author: Yanmin Zhu, MS, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital ### 1655514###Co-Author###Research Specialist###Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital###
Co-Author: Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital
### @@@ Ameet Sarpatwari, PhD, JD (he/him/his) – Brigham and Women's Hospital / Harvard Medical School ### 1360165###Co-Author###Assistant Professor of Medicine###Brigham and Women's Hospital / Harvard Medical School###
Co-Author: Ameet Sarpatwari, PhD, JD (he/him/his) – Brigham and Women's Hospital / Harvard Medical School
### he/him/his @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Co-Author###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###
Co-Author: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
### @@@ Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1655839###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Mufaddal Mahesri, MD, MPH (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1655868###Co-Author###Research Scientist###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Mufaddal Mahesri, MD, MPH (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his @@@ Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School ### 1991353###Co-Author###Research Assistant###Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School###
Co-Author: Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
### @@@ Heidi Zakoul, BA – Brigham and Women's Hospital - Division of Pharmacoepidemiology ### 1991320###Co-Author######Brigham and Women's Hospital - Division of Pharmacoepidemiology###
Co-Author: Heidi Zakoul, BA – Brigham and Women's Hospital - Division of Pharmacoepidemiology
### @@@ Seanna Vine – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1397958###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###
Co-Author: Seanna Vine – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
### @@@ Helen Mogun – Brigham and Women's Hospital ### 2325282###Co-Author######Brigham and Women's Hospital###
Co-Author: Helen Mogun – Brigham and Women's Hospital
### @@@ Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration ### 1360117###Co-Author###Associate Director for Research and Strategic Initiatives###US Food and Drug Administration###
Co-Author: Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration
### @@@ Cynthia LaCivita, PharmD – US Food and Drug Administration ### 1993690###Co-Author###Director Division of RIsk Managment###US Food and Drug Administration###
Co-Author: Cynthia LaCivita, PharmD – US Food and Drug Administration
### @@@ Esther H. Zhou, MD, PhD – U.S. Food and Drug Administration ### 1062973###Co-Author###Epidemiologist###U.S. Food and Drug Administration###
Co-Author: Esther H. Zhou, MD, PhD – U.S. Food and Drug Administration
### @@@ Claudia B. Manzo, PharmD – FDA ### 2325284###Co-Author###Office Director###FDA###
Co-Author: Claudia B. Manzo, PharmD – FDA
### @@@ Gerald J. Dal Pan, MD, MHS – US Food and Drug Administration ### 1046835###Co-Author###Medical epidemiologist###US Food and Drug Administration###
Co-Author: Gerald J. Dal Pan, MD, MHS – US Food and Drug Administration
### @@@ Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1359931###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
###
Impact of the US Food and Drug Administration Warning for Increased Risk of Aortic Aneurysms or Dissections on Fluoroquinolone Prescribing Trends

John G. Rizk, BSPharm, MSc – University of Maryland, Baltimore ### 2325441###Presenting Author###PhD Candidate###University of Maryland, Baltimore###
Presenting Author: John G. Rizk, BSPharm, MSc – University of Maryland, Baltimore
### @@@ Julia F. Slejko, PhD – University of Maryland School of Pharmacy ### 1402426###Co-Author###Associate Professor###University of Maryland School of Pharmacy###
Co-Author: Julia F. Slejko, PhD – University of Maryland School of Pharmacy
### @@@ Emily Heil, PharmD, MS – University of Maryland, Baltimore ### 2325532###Co-Author###Professor###University of Maryland, Baltimore###
Co-Author: Emily Heil, PharmD, MS – University of Maryland, Baltimore
### @@@ Dominique Seo – University of Maryland, Baltimore ### 2325533###Co-Author######University of Maryland, Baltimore###
Co-Author: Dominique Seo – University of Maryland, Baltimore
### @@@ Danya M. Qato, PhD, PharmD, MPH – University of Maryland, Baltimore ### 1655816###Co-Author###Associate Professor###University of Maryland, Baltimore###
Co-Author: Danya M. Qato, PhD, PharmD, MPH – University of Maryland, Baltimore
###
Impacts of Dobbs Decision and COVID-19 on Abortion-related Trends within TriNetX Electronic Medical Record Data

Sara A. Ephross – Syneos Health ### 2329294###Presenting Author######Syneos Health###
Presenting Author: Sara A. Ephross – Syneos Health
### @@@ Nicole Carneal-Frazer, PhD – Syneos Health ### 2330592###Co-Author###Associate Director, Epidemiology###Syneos Health###
Co-Author: Nicole Carneal-Frazer, PhD – Syneos Health
### @@@ Jacquelyne Brauneis – Syneos Health ### 2330595###Co-Author######Syneos Health###
Co-Author: Jacquelyne Brauneis – Syneos Health
### @@@ Jessica D. Albano – Syneos Health ### 2330593###Co-Author######Syneos Health###
Co-Author: Jessica D. Albano – Syneos Health
###
Improvements of Machine Learning Predictions of Overall Survival After Multiple Imputations for Features Regardless of Their Missing Degrees

HOA LE, MD, PhD (he/him/his) – Daiichi Sankyo ### 1993775###Presenting Author###Director###Daiichi Sankyo###
Presenting Author: HOA LE, MD, PhD (he/him/his) – Daiichi Sankyo
### he/him/his @@@ Yoko Tanaka, PhD – Daiichi Sankyo ### 1993853###Co-Author######Daiichi Sankyo###
Co-Author: Yoko Tanaka, PhD – Daiichi Sankyo
### @@@ Stas Zakharkin – Daiichi Sankyo ### 2325644###Co-Author######Daiichi Sankyo###
Co-Author: Stas Zakharkin – Daiichi Sankyo
###
Incidence and Survival of Pregnancy Associated Breast Cancer: A Contribution from the IMI ConcePTION Project Piloted in Finland and Norway

Maarit K. Leinonen, MD, PhD – Knowledge Brokers, Finnish Institute for Health and Welfare; Teratology Information Service, Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland ### 1358190###Presenting Author###Associate professor###Knowledge Brokers, Finnish Institute for Health and Welfare; Teratology Information Service, Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland###
Presenting Author: Maarit K. Leinonen, MD, PhD – Knowledge Brokers, Finnish Institute for Health and Welfare; Teratology Information Service, Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
### @@@ Visa Martikainen – Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland ### 1359729###Co-Author###Data manager, statistician###Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland###
Co-Author: Visa Martikainen – Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
### @@@ Cori Campbell, DPhil – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 2325296###Co-Author###Assistant Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###
Co-Author: Cori Campbell, DPhil – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 2325297###Co-Author######Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Alexis Krumme, ScD (she/her/hers) – Johnson & Johnson, Titusville, New Jersey, USA ### 1993399###Co-Author###Associate Director###Johnson & Johnson, Titusville, New Jersey, USA###
Co-Author: Alexis Krumme, ScD (she/her/hers) – Johnson & Johnson, Titusville, New Jersey, USA
### she/her/hers @@@ Joan K. Morris – Population Health Research Institute, St George’s, University of London, UK ### 1900343###Co-Author###Professor###Population Health Research Institute, St George’s, University of London, UK###
Co-Author: Joan K. Morris – Population Health Research Institute, St George’s, University of London, UK
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers @@@ Mika Gissler, PhD – Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland ### 1360036###Co-Author###Professor###Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland###
Co-Author: Mika Gissler, PhD – Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
###
Incorporating real-world data and mathematical modelling to estimate the undiagnosed Chronic hepatitis C population

William W.L. Wong, PhD – School of Pharmacy, University of Waterloo ### 1661008###Presenting Author###Associate Professor###School of Pharmacy, University of Waterloo###
Presenting Author: William W.L. Wong, PhD – School of Pharmacy, University of Waterloo
### @@@ Zeny feng – Department of Mathematics and Statistics, University of Guelph ### 2325233###Co-Author######Department of Mathematics and Statistics, University of Guelph###
Co-Author: Zeny feng – Department of Mathematics and Statistics, University of Guelph
###
Increasing retention in a large-scale, remote wearable device study: learnings from the COVID-RED trial

Duco Veen, PhD – Department of Methodology and Statistics, Utrecht University, Utrecht, the Netherlands ### 2330980###Co-Author######Department of Methodology and Statistics, Utrecht University, Utrecht, the Netherlands###
Co-Author: Duco Veen, PhD – Department of Methodology and Statistics, Utrecht University, Utrecht, the Netherlands
### @@@ Marianna Mitratza, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. ### 2330981###Co-Author######Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.###
Co-Author: Marianna Mitratza, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
### @@@ Timo B. Brakenhoff, PhD – Julius Clinical ### 2330982###Co-Author######Julius Clinical###
Co-Author: Timo B. Brakenhoff, PhD – Julius Clinical
### @@@ Brianna M. Goodale, PhD – Julius Clinical ### 2325903###Co-Author###Head of Data Science###Julius Clinical###
Co-Author: Brianna M. Goodale, PhD – Julius Clinical
### @@@ Laura C. Zwiers, MPhil – Julius Clinical ### 2325902###Presenting Author###Scientific Officer, PhD Candidate###Julius Clinical###
Presenting Author: Laura C. Zwiers, MPhil – Julius Clinical
### @@@ Paul Klaver – Julius Clinical ### 2330983###Co-Author######Julius Clinical###
Co-Author: Paul Klaver – Julius Clinical
### @@@ Kay Y. Hage – Julius Clinical ### 2330984###Co-Author######Julius Clinical###
Co-Author: Kay Y. Hage – Julius Clinical
### @@@ George S. Downward, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. ### 2330985###Co-Author######Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.###
Co-Author: George S. Downward, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
### @@@ Diederick E. Grobbee, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands ### 1993358###Co-Author###Professor of Clinical Epidemiology###Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands###
Co-Author: Diederick E. Grobbee, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands
###
Influence of mRNA Covid-19 Vaccine Dosing Interval on the Risk of Myocarditis

Stéphane Le Vu – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1655649###Presenting Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Presenting Author: Stéphane Le Vu – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Marion Bertrand – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1359610###Co-Author###MSc###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Marion Bertrand – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Laura Semenzato, MSc (she/her/hers) – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360498###Co-Author###Statistician - PhD candidate in Pharmacoepidemiology###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Laura Semenzato, MSc (she/her/hers) – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### she/her/hers @@@ Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360145###Co-Author###Epidemiologist###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Jérémie Botton, PhD, PharmD, MPH – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360499###Co-Author###PhD, PharmD, MPH###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Jérémie Botton, PhD, PharmD, MPH – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360500###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358499###Co-Author###deputy director###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1093512###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
###
Inhaler Utilization Patterns among Medicare Beneficiaries (2008-2020): Towards Sustainable Prescribing Practices in the US

Ashwaghosha Parthasarathi, MBBS – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research ### 2325687###Co-Author######Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research###
Co-Author: Ashwaghosha Parthasarathi, MBBS – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research
### @@@ Catherine Chen – Department of Medicine, Rutgers Robert Wood Johnson Medical School ### 2325690###Co-Author######Department of Medicine, Rutgers Robert Wood Johnson Medical School###
Co-Author: Catherine Chen – Department of Medicine, Rutgers Robert Wood Johnson Medical School
### @@@ Poonam Gandhi, MS – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research ### 1359859###Co-Author###Research Project Manager###Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research###
Co-Author: Poonam Gandhi, MS – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research
### @@@ Mary Bridgeman – Rutgers University Ernest Mario School of Pharmacy ### 2325696###Co-Author######Rutgers University Ernest Mario School of Pharmacy###
Co-Author: Mary Bridgeman – Rutgers University Ernest Mario School of Pharmacy
### @@@ Amy Li – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research ### 2325702###Co-Author######Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research###
Co-Author: Amy Li – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research
### @@@ Isao Iwata – Penn Medicine Princeton Health ### 2325703###Co-Author######Penn Medicine Princeton Health###
Co-Author: Isao Iwata – Penn Medicine Princeton Health
### @@@ Padukudru Anand Mahesh – Department of Respiratory Medicine, JSS Medical College ### 2325704###Co-Author######Department of Respiratory Medicine, JSS Medical College###
Co-Author: Padukudru Anand Mahesh – Department of Respiratory Medicine, JSS Medical College
### @@@ Soko Setoguchi, MD, DrPH – Rutgers University ### 1302720###Presenting Author###Professor of Medicine and Epidemiology###Rutgers University###
Presenting Author: Soko Setoguchi, MD, DrPH – Rutgers University
###
Initiating Antidepressant Treatment in Pregnancy: Timing, Intensity, and Influential Maternal and Familial Factors

Alexis Carson, MPH – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 2325271###Presenting Author###PhD Candidate###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Presenting Author: Alexis Carson, MPH – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1655801###Co-Author###Postdoctoral Fellow###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers @@@ Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1063068###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
###
Initiation of SGLT2i vs GLP1-RA and the Risk of Chronic Kidney Disease in Persons with Type 2 Diabetes Mellitus

Simon K. Jensen, MD, PhD (he/him/his) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1655428###Presenting Author###Epidemiologist###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Presenting Author: Simon K. Jensen, MD, PhD (he/him/his) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### he/him/his @@@ Uffe Heide-Jørgensen, MSc, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1655336###Co-Author###Statistician###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Uffe Heide-Jørgensen, MSc, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Ina T. Andersen, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 2325250###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Ina T. Andersen, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Reimar W W. Thomsen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1063102###Co-Author###Professor and Consultant Physician###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Reimar W W. Thomsen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Christian Fynbo Christiansen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1062563###Co-Author###Professor###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Christian Fynbo Christiansen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
###
Innovative Self-controlled Risk Interval Analysis of Effectiveness of COVID-19 mRNA Booster Vaccination in the Veterans Health Administration, Omicron Predominant Period

Caroline Korves, ScD – White River Junction Veterans Affairs Medical Center ### 1991421###Co-Author###Epidemiologist###White River Junction Veterans Affairs Medical Center###
Co-Author: Caroline Korves, ScD – White River Junction Veterans Affairs Medical Center
### @@@ Martin Kulldorff, PhD – Acumen, LLC ### 1658760###Co-Author######Acumen, LLC###
Co-Author: Martin Kulldorff, PhD – Acumen, LLC
### @@@ Abirami S. Balajee, MPH – White River Junction Veterans Affairs Medical Center ### 1991423###Co-Author######White River Junction Veterans Affairs Medical Center###
Co-Author: Abirami S. Balajee, MPH – White River Junction Veterans Affairs Medical Center
### @@@ Jeremy Smith, MPH – White River Junction Veterans Affairs Medical Center ### 1991425###Co-Author######White River Junction Veterans Affairs Medical Center###
Co-Author: Jeremy Smith, MPH – White River Junction Veterans Affairs Medical Center
### @@@ Gabrielle M. Zwain, BA – White River Junction Veterans Affairs Medical Center ### 1991424###Co-Author######White River Junction Veterans Affairs Medical Center###
Co-Author: Gabrielle M. Zwain, BA – White River Junction Veterans Affairs Medical Center
### @@@ David J. Graham, MD, MPH – US Food and Drug Administration ### 1655356###Co-Author###Associate director###US Food and Drug Administration###
Co-Author: David J. Graham, MD, MPH – US Food and Drug Administration
### @@@ Jurandir Dalle Lucca, MD, PhD – White River Junction Veterans Affairs Medical Center ### 2325405###Co-Author######White River Junction Veterans Affairs Medical Center###
Co-Author: Jurandir Dalle Lucca, MD, PhD – White River Junction Veterans Affairs Medical Center
### @@@ Hector S. Izurieta, MD, PhD – US Food and Drug Administration ### 1659297###Presenting Author###Associate Director, OVRR/CBER###US Food and Drug Administration###
Presenting Author: Hector S. Izurieta, MD, PhD – US Food and Drug Administration
###
Intermediate Pharmacoepidemiology: Approaches to Unmeasured Confounders

Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1046824###Lead Speaker###Associate Professor###University of North Carolina at Chapel Hill###
Lead Speaker: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1088164###Speaker###Assistant Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###
Speaker: Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### she/her/hers @@@ Mugdha Gokhale, PhD – Pfizer ### 1088166###Speaker###Director, Value & Evidence###Pfizer###
Speaker: Mugdha Gokhale, PhD – Pfizer
### @@@ Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1062525###Speaker###Professor###University of North Carolina at Chapel Hill###
Speaker: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet ### 1932107###Speaker###Postdoctoral Researcher###CAUSALab at IMM, Karolinska Institutet###
Speaker: Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet
### she/her/hers
Intermediate/Advanced Topics in Vaccine Safety and Effectiveness

Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc. ### 2327781###Lead Speaker###Director, Global Safety Epidemiology###Moderna, Inc.###
Lead Speaker: Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute ### 1659086###Lead Speaker###Senior Research Scientist###Harvard Pilgrim Health Care Institute###
Lead Speaker: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute
### she/her/hers @@@ Henok Tadesse Ayele, PhD – Merck & Co., Inc. ### 1062670###Speaker###Principal Scientist###Merck & Co., Inc.###
Speaker: Henok Tadesse Ayele, PhD – Merck & Co., Inc.
### @@@ Kaatje Bollaerts, PhD – P95 Epidemiology & Pharmacovigilance ### 2329038###Speaker###Epidemiology Business Head###P95 Epidemiology & Pharmacovigilance###
Speaker: Kaatje Bollaerts, PhD – P95 Epidemiology & Pharmacovigilance
### @@@ Robert T. Chen, MA, MD, FISPE (he/him/his) – Brighton Collaboration ### 1088150###Speaker###Scientific Director###Brighton Collaboration###
Speaker: Robert T. Chen, MA, MD, FISPE (he/him/his) – Brighton Collaboration
### he/him/his @@@ Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc. ### 1655853###Speaker###Director, Global Safety Epidemiologist###Moderna, Inc.###
Speaker: Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ Hector S. Izurieta, MD, PhD – US Food and Drug Administration ### 1659297###Speaker###Associate Director, OVRR/CBER###US Food and Drug Administration###
Speaker: Hector S. Izurieta, MD, PhD – US Food and Drug Administration
### @@@ Katherine E. Mues, PhD, MPH – Aetion, Inc. ### 1655854###Speaker###Vice President###Aetion, Inc.###
Speaker: Katherine E. Mues, PhD, MPH – Aetion, Inc.
###
Introduction to Drug Utilization Research

Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands ### 1086986###Lead Speaker###PhD, FISPE###Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands###
Lead Speaker: Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
### @@@ Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark ### 1358115###Lead Speaker###Assistant professor###University of Southern Denmark###
Lead Speaker: Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark
### @@@ Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia ### 2326851###Speaker###Professor###Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia###
Speaker: Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
### @@@ Lisa G. Pont, PhD, FISPE – University of Technology Sydney ### 1655255###Speaker###Professor of Pharmacy###University of Technology Sydney###
Speaker: Lisa G. Pont, PhD, FISPE – University of Technology Sydney
### @@@ Indre Treciokiene, Dr. (she/her/hers) – Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University ### 1093644###Speaker###Associate professor###Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University###
Speaker: Indre Treciokiene, Dr. (she/her/hers) – Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University
### she/her/hers @@@ Björn Wettermark, MscPharm, PhD (he/him/his) – Pharmacoepidemiology, Department of Pharmacy, Uppsala University, 752 36 Uppsala, Sweden ### 1358174###Speaker###Professor###Pharmacoepidemiology, Department of Pharmacy, Uppsala University, 752 36 Uppsala, Sweden###
Speaker: Björn Wettermark, MscPharm, PhD (he/him/his) – Pharmacoepidemiology, Department of Pharmacy, Uppsala University, 752 36 Uppsala, Sweden
### he/him/his
Intussusception Risk after Rotavirus Vaccination in Korean Infants

Haerin Cho, MA – Ewha Womans University ### 1660195###Presenting Author###PhD student###Ewha Womans University###
Presenting Author: Haerin Cho, MA – Ewha Womans University
### @@@ Na-Young Jeong, PhD – Ewha Womans University ### 1062838###Co-Author###Postdoctoral researcher###Ewha Womans University###
Co-Author: Na-Young Jeong, PhD – Ewha Womans University
### @@@ Hee-Jin Kim, MA – Ewha Womans University ### 1063354###Co-Author###PhD student###Ewha Womans University###
Co-Author: Hee-Jin Kim, MA – Ewha Womans University
### @@@ Nam-Kyong Choi – Ewha Womans University ### 1660178###Co-Author######Ewha Womans University###
Co-Author: Nam-Kyong Choi – Ewha Womans University
###
Investigating the association between Incretin-based therapies and thyroid cancer incidence using United States Medicare data 2007-2019

Clement Acheampong, B.Pharm, MPH – University of North Carolina at Chapel Hill ### 2325331###Presenting Author###PhD Student###University of North Carolina at Chapel Hill###
Presenting Author: Clement Acheampong, B.Pharm, MPH – University of North Carolina at Chapel Hill
### @@@ John Buse, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism ### 1991568###Co-Author######University of North Carolina School of Medicine Division of Endocrinology and Metabolism###
Co-Author: John Buse, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism
### @@@ Klara R. Klein, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism ### 2329810###Co-Author######University of North Carolina School of Medicine Division of Endocrinology and Metabolism###
Co-Author: Klara R. Klein, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism
### @@@ Lawrence T. Kim, MD – University of North Carolina ### 2329811###Co-Author###Professor###University of North Carolina###
Co-Author: Lawrence T. Kim, MD – University of North Carolina
### @@@ Joshua Evron, MD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism ### 2329812###Co-Author######University of North Carolina School of Medicine Division of Endocrinology and Metabolism###
Co-Author: Joshua Evron, MD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism
### @@@ Anna Kahkoska, MD, PhD – University of North Carolina at Chapel Hill ### 2329813###Co-Author######University of North Carolina at Chapel Hill###
Co-Author: Anna Kahkoska, MD, PhD – University of North Carolina at Chapel Hill
### @@@ Caroline A. Thompson, PhD – University of North Carolina at Chapel Hill ### 2329814###Co-Author######University of North Carolina at Chapel Hill###
Co-Author: Caroline A. Thompson, PhD – University of North Carolina at Chapel Hill
### @@@ Virginia Pate, MS – University of North Carolina at Chapel Hill ### 1358426###Co-Author###Analyst###University of North Carolina at Chapel Hill###
Co-Author: Virginia Pate, MS – University of North Carolina at Chapel Hill
### @@@ Peter Leese – NC TraCS Institute, School of Medicine, University of North Carolina at Chapel Hill ### 2329815###Co-Author###Director, Data Science Lab###NC TraCS Institute, School of Medicine, University of North Carolina at Chapel Hill###
Co-Author: Peter Leese – NC TraCS Institute, School of Medicine, University of North Carolina at Chapel Hill
### @@@ Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1062525###Co-Author###Professor###University of North Carolina at Chapel Hill###
Co-Author: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his
Is gabapentin used as an alternative for opioids? Characterizing gabapentin initiation in Medicare beneficiaries

GYeon Oh, PhD – University of Kentucky, Department of Epidemiology and Environmental Health ### 2330996###Presenting Author###Postdoctoral Scholar###University of Kentucky, Department of Epidemiology and Environmental Health###
Presenting Author: GYeon Oh, PhD – University of Kentucky, Department of Epidemiology and Environmental Health
### @@@ Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA ### 1358307###Co-Author###Professor###University of Kentucky, College of Pharmacy, Lexington, KY, USA###
Co-Author: Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA
### she/her/hers @@@ Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy ### 1656010###Co-Author###Professor###University of Kentucky College of Pharmacy###
Co-Author: Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy
### @@@ Erin L. Abner, PhD – University of Kentucky, Department of Epidemiology and Environmental Health ### 2330997###Co-Author######University of Kentucky, Department of Epidemiology and Environmental Health###
Co-Author: Erin L. Abner, PhD – University of Kentucky, Department of Epidemiology and Environmental Health
###
Is low socioeconomic position associated with mortality among mechanically ventilated patients in Denmark?

Noelle M. Cocoros, DSc, MPH – Harvard Pilgrim Health Care Institute, Dept. of Population Medicine ### 2325327###Presenting Author###Principal Research Scientist###Harvard Pilgrim Health Care Institute, Dept. of Population Medicine###
Presenting Author: Noelle M. Cocoros, DSc, MPH – Harvard Pilgrim Health Care Institute, Dept. of Population Medicine
### @@@ Erzsébet Horváth-Puhó – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1655233###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Co-Author: Erzsébet Horváth-Puhó – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Lise S. Skovgaard Svingel – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1655268###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Co-Author: Lise S. Skovgaard Svingel – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1359288###Co-Author###Professor & Chair###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Co-Author: Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
###
ISPE Board of Directors' Lunch & Meeting
ISPE Board of Directors' Meeting